ArticleAIDS and behavior2026
Methamphetamine Use and HIV Risk Behaviors in a Cohort of Homeless-Experienced Adults Who Use Drugs.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Methamphetamine use has increased substantially in the United States, particularly among people experiencing homelessness. While the association between methamphetamine use and HIV risk has been studied in other populations, its impact on HIV risk behaviors among people experiencing homelessness remains less well-studied. The objective of this study was to evaluate the relationship between methamphetamine use and HIV risk behaviors in a cohort of people experiencing homelessness who use drugs. We conducted a cross-sectional survey of adults with recent drug use recruited from three homeless-serving clinical sites in Boston, Massachusetts, between February 2024 and January 2025. The primary exposure was past 3-month methamphetamine use (any vs. none). The primary outcome was a composite measure of HIV risk behavior in the past 3 months, categorized as low (0 events), moderate (1-11 events), or high (≥ 12 events), based on self-reported condomless sex and shared needle events. Secondary outcomes included sex-related and injection-related HIV risk behaviors, examined separately. We used multinomial logistic regression to assess associations with overall and sex-related HIV risk behaviors, and bivariate analyses for injection-related HIV risk behavior due to sparse outcome data. Of 196 participants, the mean age was 48 years. 60% identified as cis-gender male, 56% as White, 31% as Black, and 20% as Hispanic. Methamphetamine use in the past 3 months was reported by 42% of participants. Its use was not independently associated with overall HIV risk behavior (aRR for high vs. low risk: 2.20; 95% CI: 0.84-5.77) or sex-related HIV risk behavior (aRR for high vs. low risk: 1.45; 95% CI: 0.53-4.00). However, in bivariate analyses, methamphetamine use was significantly associated with injection-related HIV risk behaviors: individuals who used methamphetamine were less likely to have low-risk behavior (27% vs. 79%) and more likely to have moderate-risk (43% vs. 8%) and high-risk (31% vs. 4%) behaviors (P < 0.001). Among homeless-experienced adults who use drugs, methamphetamine use was associated with higher-risk injection behaviors but not with sex-related HIV risk behaviors. HIV prevention strategies in this population should prioritize safer injection practices, evidence-based methamphetamine treatment, and equitable access to pre-exposure prophylaxis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.